UFP Technologies Earnings Call Highlights Growth and Investment

UFP Technologies reported Q3 sales growth of 11.6% to $172.4M, driven by MedTech demand. Gross margin improved to 29.4%, and adjusted EPS rose to $2.88. The company highlighted capacity investments and acquisitions, including CI Medical. Challenges include AJR transfer delays and higher SG&A costs. Management expects long-term growth of 6-9% organically and 12-18% with acquisitions, with a softer fourth quarter.

Original reporting
Published Nov 15, 2026, 3:55 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 15, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$UFPT
Bullish
high confidence
Mentioned
$UFPT
Relevance
6/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$UFPTBullishMed
01

Why it matters

The earnings beat and cash generation support a bullish outlook, though execution risks remain.

02

Market read

First disclosure of Q3 results for UFPT; provides fresh data for traders evaluating MedTech small caps.

03

What to watch

Robotic‑surgery segment flat to down and delayed AJR transfers may constrain future growth.

Relevance 6/10Novelty 7/10Timing: post‑earnings today

Background

UFP Technologies (UFPT) released its Q3 earnings call, detailing financial performance and strategic initiatives.

Company-level read

Ticker impact

$UFPTBullishHigh confidence
Context

Q3 sales rose 11.6% to $172.4M, margin improved to 29.4%, and operating cash flow hit $38.5M.

Expected impact

likely upward pressure as market prices in better-than-expected growth and margins

Evidence & confidence

First report of Q3 results with double‑digit revenue growth and improved profitability.

Market effects

Highlights strength in MedTech and medical plastics, may boost peers in the sector.

U.S. small‑cap biotech/medical device space sees modest lift.

Limited to niche medical‑technology segment.

Counterpoint

Margin headwinds from AJR transfers and higher SG&A could weigh on near‑term earnings.

Key entities

  • UFP Technologies

    Medical‑technology manufacturer reporting Q3 results.

Related articles

$UFPTMed

UFP Technologies (UFPT) Shares Just Moved, So What Is Driving Attention Now?

UFP Technologies (UFPT) reported Q3 sales of $172.43M and net income of $20.62M, up from the previous year. Shares rose 17.66% to $329.82 on the news, extending a 15.32% 7-day return. Analysts see a fair value of $355, citing growth in medical device components and packaging. However, UFPT trades at 33.4x earnings, higher than the industry average of 23.9x, raising valuation concerns.

$UFPTMed

UFP Technologies (UFPT) Q3 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q3 2026 sales up 11.6%, with organic growth at 11.1%. Gross margin improved to 29.4% from 27.7% last year. Adjusted EPS was $2.88, up significantly. The company is investing in growth, including acquisitions like CI Medical, and expanding credit facilities. AJR operations are behind schedule but expected to improve in 2027. Management remains optimistic about long-term growth and shareholder value.

$UFPTHighAI 8/10

UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026

UFP Technologies (UFPT) reported Q3 2026 revenue of $172.4M, up 11.6% YoY and 3.2% above estimates. Adjusted EPS of $2.88 beat estimates by 7.3%. Operating margin held steady at 16%. The company cited operational improvements and growth in new programs. Analysts expect 5.6% revenue growth over the next 12 months.

$UFPTHigh

UFP Technologies Announces Strong Q3 Results

UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. UFP Technologies Announces Strong Q3 Results Newburyport, Mass., November 3, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly